|
Market Cap (17-Jun) $827,996,160 (700th) |
Close (30-Jun) $0.70 |
Volume (30-Jun) 56,305 |
Shortsold (26-May) 28,715,960 (7.70%) (37th) |
|
52w High $5.87 |
52w Low $1.97 |
P/E - |
EPS -0.28 |
A news article has been posted about Clarity Pharmaceuticals on the AFR. The article was published around , on 30 July 2024 at 12:49pm.
Clarity Pharmaceuticals reports it eliminated prostate cancer in a patient; LTR Pharma wants to sell nasal viagra; and Opthea has clinical trial results soon.
Read ArticleCU6 was $0.70 at the close of trade on 30 June 2023
| Recent Articles about ASX:CU6 | |
|---|---|
| 27-Dec | ASX rises on post Christmas trading
msn.com |
| 27-Dec | Clarity Pharmaceuticals Ltd (CU6)
au.investing.com |
| 20-Dec | Hot Stocks: Exosome Breakthrough, Gas Pipeline Deals and More
sharecafe.com.au |
| 20-Dec | Clarity Pharmaceuticals Ltd CU6
morningstar.com |
| 19-Dec | Clarity Pharmaceuticals develops novel FAP-targeted radiopharmaceutical
bioworld.com |
| 19-Dec | Clarity expands its pipeline with a novel optimised FAP-targeted radiopharmaceutical
vietreader.com |
| 18-Dec | Clarity Pharmaceuticals (ASX:CU6) Launches New Cancer Radiopharmaceutical
kalkinemedia.com |
| 18-Dec | Clarity Expands Its Pipeline With A Novel Optimised FAP-Targeted Radiopharmaceutical
menafn.com |
| 18-Dec | Clarity Pharmaceuticals Lists New Securities on ASX
markets.businessinsider.com |
| 18-Dec | Why Clarity, Omni Bridgeway, Santana Minerals, and Vulcan shares are pushing higher today
msn.com |
| Tracked |
Find all articles about Clarity Pharmaceuticals, including others on the AFR, on the media page.
You must be logged in to post a reply.
